“Ivermectin was effective against omicron in phase 3 clinical trials.”
Social media posts
Claim dated 31 Jan 2022.
FactCheck.org rated thisFalse
What FactCheck.org found
A Japanese pharmaceuticals company found that ivermectin showed an “antiviral effect” against the omicron variant in a lab setting -- not a phase 3 clinical trial with human test subjects.
Their words, from the summary they publish with the rating.
In short
This claim spread on social media around 31 January 2022. FactCheck.org (United States) looked into it and published its finding on 2 February 2022, 2 days later. Its rating was “False”.
This check was done by FactCheck.org, not by DoesItStand. We list it so you can find it. Their full evidence and reasoning are in their article.